Corvus Pharmaceuticals, Inc. (CRVS): Weighted Average Diluted Shares
79.74M
Year ended 2025-12-31
+19.7%
3-year compound annual growth
+22.0%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 79.74M | +30.8% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | 60.99M | +27.0% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | 48.03M | +3.2% | 2026-03-12, From 2023-01-01 |
| 2022-12-31 | 46.55M | +11.2% | 2025-03-25, From 2022-01-01 |
| 2021-12-31 | 41.85M | +42.0% | 2024-03-19, From 2021-01-01 |
| 2020-12-31 | 29.48M | +0.4% | 2023-03-28, From 2020-01-01 |
| 2019-12-31 | 29.35M | n/a | 2022-03-10, From 2019-01-01 |